EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Nigopan Gopalasingam iD, Kristoffer Berg-Hansen iD, Kristian Hylleberg Christensen, Bertil T Ladefoged iD, Steen Hvitfeldt Poulsen, Mads Jønsson Andersen iD, Barry A Borlaug iD, Roni Nielsen iD, Niels Møller iD, Henrik Wiggers iD

Circulation · 12.11.2024 · 150 (20) · 1570-1583

DOI: 10.1161/circulationaha.124.069732 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 12.11.2024. Verfasst von Nigopan Gopalasingam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aarhus University Hospital, Denmark (N.G., K.B.-H., K.H.C., B.T.L., S.H.P., M.J.A., R.N., H.W.). Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Heart Failure, Stroke Volume, Cross-Over Studies. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a major cause of morbidity and mortality in patients with type 2 diabetes (T2D). Acute increases in circulating levels of ketone body 3-hydroxybutyrate have beneficial acute hemodynamic effects in patients without T2D with chronic heart failure with reduced ejection fraction. However, the cardiovascular effects of prolonged oral ketone ester (KE) treatment in patients with T2D and HFpEF remain unknown. METHODS: A total of 24 patients with T2D and HFpEF completed a 6-week randomized, double-blind crossover study. All patients received 2 weeks of KE treatment (25 g D-ß-hydroxybutyrate-(R)-1,3-butanediol × 4 daily) and isocaloric and isovolumic placebo, separated by a 2-week washout period. At the end of each treatment period, patients underwent right heart catheterization, echocardiography, and blood samples at trough levels of intervention, and then during a 4-hour resting period after a single dose. A subsequent second dose was administered, followed by an exercise test. The primary end point was cardiac output during the 4-hour rest period. RESULTS: During the 4-hour resting period, circulating 3-hydroxybutyrate levels were 10-fold higher after KE treatment (1010±56 µmol/L; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Heart FailureStroke VolumeCross-Over StudiesHumansMaleFemaleAgedDouble-Blind MethodMiddle Aged3-Hydroxybutyric AcidEstersTreatment OutcomeCardiac OutputVentricular Function, Left

Stichwörter der Autor:innen

3-hydroxybutyratecardiac outputestersexerciseheart failure, diastolichemodynamicsketone esterketonesmetabolism

Substanzen

3-Hydroxybutyric AcidEsters

Autor:innen und Institutionen

  • Department of Cardiology, Aarhus University Hospital, Denmark (N.G., K.B.-H., K.H.C., B.T.L., S.H.P., M.J.A., R.N., H.W.).
  • Department of Clinical Medicine (N.G., K.B.-H., K.H.C., B.T.L., S.H.P., M.J.A., R.N., N.M., H.W.), Aarhus University, Denmark.
  • Department of Cardiovascular Medicine, Mayo Clinic Hospital, Rochester, MN (B.A.B.).
  • Department of Endocrinology and Metabolism (N.M.), Aarhus University, Denmark.

ORCID-Profile: Nigopan Gopalasingam, Kristoffer Berg-Hansen, Bertil T Ladefoged, Mads Jønsson Andersen, Barry A Borlaug, Roni Nielsen, Niels Møller, Henrik Wiggers

Zitieren

APA

Gopalasingam, N., Berg-Hansen, K., Christensen, K. H., Ladefoged, B. T., Poulsen, S. H., Andersen, M. J., Borlaug, B. A., Nielsen, R., Møller, N., & Wiggers, H. (2024). Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Circulation, 150(20), 1570-1583. https://doi.org/10.1161/circulationaha.124.069732

Vancouver

Gopalasingam N, Berg-Hansen K, Christensen KH, Ladefoged BT, Poulsen SH, Andersen MJ, et al. Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Circulation. 2024;150(20):1570-1583. doi:10.1161/circulationaha.124.069732

BibTeX
@article{Gopalasingam2024,
  author = {Gopalasingam, Nigopan and Berg-Hansen, Kristoffer and Christensen, Kristian Hylleberg and Ladefoged, Bertil T and Poulsen, Steen Hvitfeldt and Andersen, Mads Jønsson and Borlaug, Barry A and Nielsen, Roni and Møller, Niels and Wiggers, Henrik},
  title = {Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction},
  journal = {Circulation},
  year = {2024},
  volume = {150},
  number = {20},
  pages = {1570--1583},
  doi = {10.1161/circulationaha.124.069732}
}
Kostenlos starten →